Summary
-
1.
We compared the ability of growth hormone (GH) and a wellcharacterized macrophage-activating factor, interferon-γ (IFN-γ) to activate highly purified populations of alveolar macrophages. Both GH and IFN-γ primed macrophages triggered with opsonized zymosan to secrete superoxide anion (O -2 )in vitro, but IFN-γ was effective at a 40-fold lower concentration. Antibody blocking studies demonstrated that the priming activity of GH was independent of IFN-γ, and the activity of IFN-γ was distinct from that of GH.
-
2.
Both IFN-γ and GH increased the capability of macrophages to killPasteurella multocida in vitro.
-
3.
Hypophysectomized rats challenged withSalmonella typhimurium were significantly protected by injections of either GH or recombinant rat IFN-γ in vivo compared to vehicle-treated controls, and the protective effect of GH was increased by incorporation into liposomes.
-
4.
Insulin-like growth factor-I (IGF-I) also primed alveolar macrophagesin vitro, which is consistent with the idea that the protective effects of GHin vivo might be mediated by augmenting the synthesis of IGF-I. These data support the concept of reciprocal systems of communication between the neuroendocrine and immune systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baxter, J. R., Blalock, J. E., and Weigent, D. A. (1991). Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone.Endocrinology 1291727–1734.
Berczi, I., and Nagy, E. (1991). Effects of hypophysectomy on immune function. InPsychoneuroimmunology, 2nd ed. (R. Ader, D. Felten, and N. Cohen, Eds.), Academic Press, New York, pp. 339–375.
Berczi, I., Nagy, E., de Toledo, S. M., Matusik, R. J., and Friesen, H. G. (1991). Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue.J. Immunol. 1462201–2206.
Bernton, E. W., Meltzer, M. S., and Holaday, J. W. (1988). Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice.Science 239401–404.
Blalock, J. E. (1989). A molecular basis for bidirectional communication between the immune and neuroendocrine systems.Physiol. Rev. 691–27.
Crist, D. M., Peake, G. T., MacKinnon, L. T., Sibbit, W. L., Jr., and Kraner, J. C. (1987). Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion.Metabolism 361115–1117.
de la Fuente, J. R., and Wells, L. A. (1981). Human growth hormone in psychiatric disorders.J. Clin. Psychiat. 42270–274.
Edwards, C. K., III, Ghiasuddin, S. M., Schepper, J. M., Yunger, L. M., and Kelley, K. W. (1988). A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion.Science 239769–771.
Edwards, C. K., III, Jacobs, M. J., Meyers-Keith, P., and Yunger, L. M. (1989). Murine macrophage activation with resorcyclic acid lactones (RALs): Comparison with diethylstilbestrol and 17β estradiol.Immunopharmacology 17107–118.
Edwards, C. K., III, Yunger, L. M., Lorence, R. M., Dantzer, R., and Kelley, K. W. (1991a). The pituitary gland is required for protection against lethal effects ofSalmonella typhimurium.Proc. Natl. Acad. Sci. USA 882274–2277.
Edwards, C. K., III, Lorence, R. M., Dunham, D. M., Arkins, S., Yunger, L. M., Greager, J. A., Walter, R. J., Dantzer, R., and Kelley, K. W. (1991b). Hypophysectomy inhibits the synthesis of tumor necrosis factorα by rat macrophages: Partial restoration by exogenous growth hormone or interferonγ.Endocrinology 128989–996.
Edwards, C. K., III, Ghiasuddin, S. M., Yunger, L. M., Lorence, R. M., Arkins, S., Dantzer, R., and Kelley, K. W. (1992).In vivo administration of recombinant growth hormone or interferon-γ activates macrophages: Enhanced resistance to experimentalSalmonella typhimurium infection is correlated with the generation of reactive oxygen intermediates.Infect. Immun. 602514–2521.
Evans, D. L., and Nemeroff, C. B. 1987. Depression and aging: Psychoneuroendocrinology and psychoneuroimmunology.Prog. Neuroendocrinol. 1:21–27.
Fu, Y. K., Arkins, S., Wang, B. S., and Kelley, K. W. (1991). A novel role of growth hormone and insulin-like growth factor-I: Priming neutrophils for superoxide anion secretion.J. Immunol. 1461602–1608.
Fu, Y. K., Arkins, S., Fuh, G., Cunningham, B. C., Wells, J. A., Fong, S., Cronin, M. J., Dantzer, R., and Kelley, K. W. (1992). Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor.J. Clin. Invest. 89451–457.
Geffner, M. E., Bersch, N., Lippe, B. M., Rosenfeld, R. G., Hintz, R. L., and Golde, D. W. (1990). Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I.J. Clin. Endocrinol. Metab. 71464–469.
Gregoire, F., Branman, G., DeBuck, R., and Corvilain, J. (1977). Hormone release in depressed patients before and after recovery.Psychoneuroendocrinology 2303–312.
Gruen, P. H., Sachar, E. J., Altman, N., and Sassin, J. (1975). Growth hormone responses to hypoglycemia in postmenopausal depressed women.Arch. Gen. Psychiat. 3231–33.
Kelijman, M. (1991). Age-related alteration of the growth hormone/insulin-like-growth-factor I axisJ. Am. Geriat. Soc. 39295–307.
Kelley, K. W. (1989). Growth hormone, lymphocytes and macrophages.Biochem. Pharmacol. 38705–713.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the folin phenol reagent.J. Biol. Chem. 193265–275.
Mayhew, E., Nikolopoulos, G. T., King, J. J., and Siciliano, A. A. (1985). A practical method for the large scale manufacture of liposomes.Pharm. Manufact. 818–22.
Nagaoka, I., Trapnell, B. C., and Crystal, R. G. (1990). Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.J. Clin. Invest. 85448–455.
Poste, G., Bucana, C., Raz, A., Bugelski, P., Kirsh, R., and Fidler, I. J. (1982). Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.Cancer Res. 421412–1422.
Puig-Antich, J., Tabrizi, M. A., Davies, M., Goetz, R., Chambers, W. J., Halpern, F., and Sachar, E. J. (1981). Prepubertal endogenous major depressives hyposecrete growth hormone in response to insulin-induced hypoglycemia.Biol. Psychiat. 16801–818.
Saiki, I., and Fidler, I. J. (1985). Synergistic activation by recombinant mouse interferon-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages.J. Immunol. 135684–688.
SAS Institute (1987)SAS User's Guide. Statistics, SAS Institute, Cary, NC.
Saxena, Q. B., Saxena, R. K., and Adler, W. H. (1982). Regulation of natural killer activityin vivo. III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population.Int. Arch. Allergy Appl. Immunol. 67169–174.
Stein, M., Miller, A. H., and Trestman, R. L. (1991). Depression and the immune system. InPsychoneuroimmunology, 2nd ed. (R. Ader, D. Felten, and N. Cohen, Eds.), Academic Press, New York, pp.897–930.
Weigent, D. A., and Blalock, J. E. (1990). Growth hormone and the immune system.Prog. Neuroendocrinimmunol.3:231–241.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edwards, C.K., Arkins, S., Yunger, L.M. et al. The macrophage-activating properties of growth hormone. Cell Mol Neurobiol 12, 499–510 (1992). https://doi.org/10.1007/BF00711550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711550